Optimized Dosing Regimens of Meropenem in Septic Children Receiving Extracorporeal Life Support
Objectives: To develop a population pharmacokinetic model of meropenem in children with sepsis receiving extracorporeal life support (ECLS) and optimize the dosage regimen based on investigating the probability of target attainment (PTA).Methods: The children with sepsis were prospectively enrolled...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.699191/full |
id |
doaj-11ef7526a5cd462099876df91e2545e7 |
---|---|
record_format |
Article |
spelling |
doaj-11ef7526a5cd462099876df91e2545e72021-08-24T10:08:39ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122021-08-011210.3389/fphar.2021.699191699191Optimized Dosing Regimens of Meropenem in Septic Children Receiving Extracorporeal Life SupportYixue Wang0Weiming Chen1Yidie Huang2Guangfei Wang3Zhiping Li4Gangfeng Yan5Chao Chen6Guoping Lu7Department of Pediatric Critical Care Medicine, Children’s Hospital of Fudan University, National Children’s Medical Center, Shanghai, ChinaDepartment of Pediatric Critical Care Medicine, Children’s Hospital of Fudan University, National Children’s Medical Center, Shanghai, ChinaDepartment of Clinical Pharmacy, Children’s Hospital of Fudan University, National Children’s Medical Center, Shanghai, ChinaDepartment of Clinical Pharmacy, Children’s Hospital of Fudan University, National Children’s Medical Center, Shanghai, ChinaDepartment of Clinical Pharmacy, Children’s Hospital of Fudan University, National Children’s Medical Center, Shanghai, ChinaDepartment of Pediatric Critical Care Medicine, Children’s Hospital of Fudan University, National Children’s Medical Center, Shanghai, ChinaDepartment of Neonatology, Children’s Hospital of Fudan University, National Children’s Medical Center, Shanghai, ChinaDepartment of Pediatric Critical Care Medicine, Children’s Hospital of Fudan University, National Children’s Medical Center, Shanghai, ChinaObjectives: To develop a population pharmacokinetic model of meropenem in children with sepsis receiving extracorporeal life support (ECLS) and optimize the dosage regimen based on investigating the probability of target attainment (PTA).Methods: The children with sepsis were prospectively enrolled in a pediatric intensive care unit from January 2018 to December 2019. The concentration-time data were fitted using nonlinear mixed effect model approach by NONMEM program. The stochastic simulation considering various scenarios based on proposed population pharmacokinetics model were conducted, and the PTAs were calculated to optimize the dosage regimens.Results: A total of 25 children with sepsis were enrolled, of whom13 received ECMO, 9 received CRRT, and 4 received ECMO combined with CRRT. 12 children received a two-step 3-h infusion and 13 children received 1-h infusion. Bodyweight and creatinine clearance had significant impacts on the PK parameters. ECMO intervention was not related to the PK properties. If 100%T > MIC was chosen as target, children receiving 40 mg/kg q8h over a 3 h-infusion only reached the PTA up to 77.4%. If bacteria with MIC 2 mg/L were to be treated with meropenem and the PTA target was 50%T > MIC, a dose of 40 mg/kg q8h for 1 h infusion would be necessary.Conclusions: The PK properties of meropenem in septic children receiving extracorporeal life support were best described. We recommended the opitimized dosing regimens for septic children receiving ECLS depending on the PTA of PK target 50%T > MIC and 100%T > MIC, for children with sepsis during ECLS with different body weight, estimated creatinine clearance (eCRCL) and MIC of bacteria.https://www.frontiersin.org/articles/10.3389/fphar.2021.699191/fullmeropenempharmacokinetics/pharmacodynamicschildrensepsiseven extracorporeal membrane oxygenationcontinuous renal replacement therapy |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yixue Wang Weiming Chen Yidie Huang Guangfei Wang Zhiping Li Gangfeng Yan Chao Chen Guoping Lu |
spellingShingle |
Yixue Wang Weiming Chen Yidie Huang Guangfei Wang Zhiping Li Gangfeng Yan Chao Chen Guoping Lu Optimized Dosing Regimens of Meropenem in Septic Children Receiving Extracorporeal Life Support Frontiers in Pharmacology meropenem pharmacokinetics/pharmacodynamics children sepsis even extracorporeal membrane oxygenation continuous renal replacement therapy |
author_facet |
Yixue Wang Weiming Chen Yidie Huang Guangfei Wang Zhiping Li Gangfeng Yan Chao Chen Guoping Lu |
author_sort |
Yixue Wang |
title |
Optimized Dosing Regimens of Meropenem in Septic Children Receiving Extracorporeal Life Support |
title_short |
Optimized Dosing Regimens of Meropenem in Septic Children Receiving Extracorporeal Life Support |
title_full |
Optimized Dosing Regimens of Meropenem in Septic Children Receiving Extracorporeal Life Support |
title_fullStr |
Optimized Dosing Regimens of Meropenem in Septic Children Receiving Extracorporeal Life Support |
title_full_unstemmed |
Optimized Dosing Regimens of Meropenem in Septic Children Receiving Extracorporeal Life Support |
title_sort |
optimized dosing regimens of meropenem in septic children receiving extracorporeal life support |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Pharmacology |
issn |
1663-9812 |
publishDate |
2021-08-01 |
description |
Objectives: To develop a population pharmacokinetic model of meropenem in children with sepsis receiving extracorporeal life support (ECLS) and optimize the dosage regimen based on investigating the probability of target attainment (PTA).Methods: The children with sepsis were prospectively enrolled in a pediatric intensive care unit from January 2018 to December 2019. The concentration-time data were fitted using nonlinear mixed effect model approach by NONMEM program. The stochastic simulation considering various scenarios based on proposed population pharmacokinetics model were conducted, and the PTAs were calculated to optimize the dosage regimens.Results: A total of 25 children with sepsis were enrolled, of whom13 received ECMO, 9 received CRRT, and 4 received ECMO combined with CRRT. 12 children received a two-step 3-h infusion and 13 children received 1-h infusion. Bodyweight and creatinine clearance had significant impacts on the PK parameters. ECMO intervention was not related to the PK properties. If 100%T > MIC was chosen as target, children receiving 40 mg/kg q8h over a 3 h-infusion only reached the PTA up to 77.4%. If bacteria with MIC 2 mg/L were to be treated with meropenem and the PTA target was 50%T > MIC, a dose of 40 mg/kg q8h for 1 h infusion would be necessary.Conclusions: The PK properties of meropenem in septic children receiving extracorporeal life support were best described. We recommended the opitimized dosing regimens for septic children receiving ECLS depending on the PTA of PK target 50%T > MIC and 100%T > MIC, for children with sepsis during ECLS with different body weight, estimated creatinine clearance (eCRCL) and MIC of bacteria. |
topic |
meropenem pharmacokinetics/pharmacodynamics children sepsis even extracorporeal membrane oxygenation continuous renal replacement therapy |
url |
https://www.frontiersin.org/articles/10.3389/fphar.2021.699191/full |
work_keys_str_mv |
AT yixuewang optimizeddosingregimensofmeropeneminsepticchildrenreceivingextracorporeallifesupport AT weimingchen optimizeddosingregimensofmeropeneminsepticchildrenreceivingextracorporeallifesupport AT yidiehuang optimizeddosingregimensofmeropeneminsepticchildrenreceivingextracorporeallifesupport AT guangfeiwang optimizeddosingregimensofmeropeneminsepticchildrenreceivingextracorporeallifesupport AT zhipingli optimizeddosingregimensofmeropeneminsepticchildrenreceivingextracorporeallifesupport AT gangfengyan optimizeddosingregimensofmeropeneminsepticchildrenreceivingextracorporeallifesupport AT chaochen optimizeddosingregimensofmeropeneminsepticchildrenreceivingextracorporeallifesupport AT guopinglu optimizeddosingregimensofmeropeneminsepticchildrenreceivingextracorporeallifesupport |
_version_ |
1721197665074544640 |